Cannabinoid profiling informs patients about the concentrations of active cannabinoids in their medicine. Researchers have identified over 113 cannabinoid compounds, many of which possess distinct medicinal benefits. An test to establish the concentration of the active ingredients in a medicinal product is a requirement by the MCC (Medicines Control Council) according to GMPc (Current Good Manufacturing Practice). Potency should be tested on all medical cannabis products or derivatives thereof. As is the case with any pharmaceutical product, the active ingredients in cannabis should be clearly labelled with a concentration of these actives associated to each.
